Deep Tech Startups

NanoGuard Technologies develops sterilization technologies for medical applications.

1 investor

NanoHalen develops rapid, low-impact testing methods for analyzing the quality of drinking and domestic water. The company positions its measurement products as simpler and more environmentally friendly alternatives to existing water analysis methods.

1 investor

Nanoionix develops EcoCer, a class of permanent, self-disinfecting ceramic materials and coatings that continuously inactivate bacteria, viruses, fungi, and algae without leaching into the environment. The coatings can be applied to metal, plastic, glass, ceramic, textile, wood, and paper during manufacturing or as an aftermarket treatment.

1 investor

Nanom uses a patented top-down accelerator technology to convert micron-scale materials into controlled nanoparticles engineered for conductivity, porosity, and energy efficiency, used in batteries, electronics, and other products. Its chemical-free process also reuses battery and industrial waste to produce high-value nanomaterials for the energy storage and manufacturing sectors.

1 investor

MEGA Nanodots are magnetic collectible spheres that can be manipulated into various forms and shapes for desktop art, office games, and kinetic physics demonstrations. The product combines traditional marble collectibles with magnetic properties.

1 investor

An AI platform for materials science and nanotechnology that provides property prediction, synthesis guidance, and research briefings for R&D teams working with nanomaterials and advanced matter. The site also publishes practical guides and Q&A explaining product workflows and usage.

1 investor

NanoMedical Systems develops subcutaneous implantable drug-delivery devices built on its nStrada nanofluidics platform, which uses arrays of precision nanochannels to provide long-term, constant release of small molecules, peptides, and proteins for chronic therapies. The platform, manufactured with semiconductor methods, offers passive, refillable, and remotely controlled delivery systems for pharmaceutical and biologic drug delivery.

1 investor

Oxford Nanopore offers educational programs and tools to make DNA sequencing accessible to students and educators from high school through undergraduate levels. The company works with institutions and scientific educators to integrate nanopore sequencing technology into classroom settings and address the world's pressing challenges.

1 investor

NanoPort develops hardware technology solutions for mobile and electronic devices, including magnetic wireless connectors that share power and data, impact-based haptics, multi-device connectivity and orchestration, and grip-based input methods. The company focuses on new device form factors and human-device interaction interfaces.

1 investor

NanoProX develops bismuth sulfide (Bi₂S₃) nanoparticles administered intravenously before radiotherapy to selectively accumulate in tumors and amplify local radiation dose, aiming to increase tumor cell elimination per session without new equipment. The company targets oncology treatment and works with research institutions and clinical centers on preclinical and clinical translation.

1 investor

NanoSuit株式会社 develops the Japan-originated NanoSuit® method, a technology that enables electron microscope observation of living organisms, fixed specimens, cells, and biological particles such as viruses and exosomes in a wet or living state with minimal changes to fine structures. Spun out from Hamamatsu University School of Medicine research, it targets applications in life sciences, healthcare, cosmetics, and food.

1 investor

NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development. The company serves biotech and pharmaceutical customers working on therapeutics and medical treatments.

1 investor

Nanotica Agro develops nanoencapsulation technology that reduces required agrochemical quantities while decreasing environmental contamination and improving food security. The company provides farmers with a nanoencapsulation machine and empty capsules to process agrochemicals on-site at application time, enhancing product effectiveness at lower doses.

1 investor

NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.

1 investor

Nanoxo is a chemical materials company specializing in the design and manufacturing of functional nanomaterials, including heavy-metal-free quantum dots based on zinc oxide. The company serves emerging industries requiring advanced materials and leverages chemical research expertise to develop and commercialize innovative material solutions.

1 investor

Naoris Protocol builds Quantum Fabric, a distributed cybersecurity infrastructure that uses post-quantum cryptography, multi-party verification, and a dPoSec consensus protocol with Swarm AI to continuously validate the security posture of devices, users, and systems. It targets enterprises, governments, critical infrastructure operators, and regulated industries such as defense, banking, telecom, healthcare, and smart infrastructure.

1 investor

Nordic Alpha Partners is a venture capital firm that invests in industrial greentech companies across Northern and Continental Europe, providing capital and active value creation support to help portfolio companies scale globally during the renewable energy transition.

1 investor

Naqi Logix develops neural earbuds that detect brain waves, muscle impulses, and facial micro-gestures and convert them into digital signals to control devices hands-free, voice-free, and screen-free. The human-machine interface serves applications across gaming, mobility, accessibility, defense, and first response.

1 investor

Natsume Research Institute conducts basic research on pupillary response analysis technology, quantifying involuntary emotional reactions by scientifically measuring changes in pupil size to produce objective emotion data. The company develops measurement methods, analysis logic, and solutions applying this data across fields such as medical care, education, security, marketing, and human resources.

1 investor

Naycel converts methane and other carbon-rich feedstocks into high-purity graphite and hydrogen, offering an alternative to mining and synthetic graphite routes. It targets battery manufacturers, defense-aligned supply chains, and industrial partners needing traceable, resilient graphite supply.

1 investor

NB Health Laboratory develops antibody therapeutics for drug discovery and development to address unmet medical needs in healthcare.

1 investor

Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.

1 investor

NDITIVE develops intelligent sensing hardware systems that combine novel MEMS sensors, edge AI processing, secure connectivity, and platform software into a single technology stack. It targets industrial and field applications such as gas sensing and monitoring, with research extending toward quantum-enabled sensing.

1 investor

OpenProtein.AI (ne47.bio) develops protein language and generative AI models for end-to-end protein engineering, including de novo sequence design, variant effect prediction, in silico library screening, and training of specialized models on proprietary data. Its tools are offered to biology and computational research teams through a no-code GUI and programmatic APIs to accelerate design-build-test cycles.

1 investor